These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16309761)

  • 1. Inflammatory and vasoactive factors in the aspirate from the culprit coronary artery of patients with acute myocardial infarction.
    Ko YG; Jung JH; Park S; Choi E; Joung B; Hwang KC; Ha JW; Choi D; Jang Y; Chung N; Shim WH; Cho SY
    Int J Cardiol; 2006 Sep; 112(1):66-71. PubMed ID: 16309761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein.
    Maier W; Altwegg LA; Corti R; Gay S; Hersberger M; Maly FE; Sütsch G; Roffi M; Neidhart M; Eberli FR; Tanner FC; Gobbi S; von Eckardstein A; Lüscher TF
    Circulation; 2005 Mar; 111(11):1355-61. PubMed ID: 15753219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release and elimination of soluble vasoactive factors during percutaneous coronary intervention of saphenous vein grafts: analysis using the PercuSurge GuardWire distal protection device.
    Salloum J; Tharpe C; Vaughan D; Zhao DX
    J Invasive Cardiol; 2005 Nov; 17(11):575-9. PubMed ID: 16264199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarction.
    Ohashi Y; Kawashima S; Mori T; Terashima M; Ichikawa S; Ejiri J; Awano K
    Int J Cardiol; 2006 Sep; 112(1):52-8. PubMed ID: 16376442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of matrix metalloproteinases and interleukin-6 in the culprit coronary artery of myocardial infarction.
    Suzuki H; Kusuyama T; Sato R; Yokota Y; Tsunoda F; Sato T; Shoji M; Iso Y; Koba S; Katagiri T
    Eur J Clin Invest; 2008 Mar; 38(3):166-73. PubMed ID: 18257779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An increased platelet-leukocytes interaction at the culprit site of coronary artery occlusion in acute myocardial infarction: a pathogenic role for "no-reflow" phenomenon?
    Botto N; Sbrana S; Trianni G; Andreassi MG; Ravani M; Rizza A; Al-Jabri A; Palmieri C; Berti S
    Int J Cardiol; 2007 Apr; 117(1):123-30. PubMed ID: 16890311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early initiation of statin therapy in patients with acute myocardial infarction after successful percutaneous coronary intervention].
    Katayama N; Nakao K; Horiuchi K; Ogawa H; Honda T
    J Cardiol; 2004 Oct; 44(4):131-40. PubMed ID: 15532243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration of soluble P-selectin and white blood cell counts in infarct coronary arteries in patients with acute myocardial infarction differ from the systemic circulation.
    Yu TH; Chua S; Cheng CI; Liu WH; Chiu CA; Yang CH; Fang CY; Hsieh YK; Hang CL; Hung WC; Chen YH; Yeh KH; Fu M; Yip HK
    Chang Gung Med J; 2006; 29(2):169-74. PubMed ID: 16767965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of systemic inflammation with local inflammatory activity in non-culprit lesions: beneficial effect of statins.
    Toutouzas K; Drakopoulou M; Markou V; Karabelas I; Vaina S; Vavuranakis M; Tsiamis E; Tsioufis C; Androulakis A; Stefanadis C
    Int J Cardiol; 2007 Jul; 119(3):368-73. PubMed ID: 17258821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease.
    Taylor AJ; Bobik A; Richards M; Kaye D; Raines G; Gould P; Jennings G
    Am Heart J; 2004 Aug; 148(2):e10. PubMed ID: 15309013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of primary percutaneous coronary intervention on blood perfusion in nonculprit artery in patients with anterior ST elevation myocardial infarction.
    Wang J; Liu JH; Zheng B; Zhang M; Wang SP; Zheng Z
    Chin Med J (Engl); 2013 Jan; 126(1):22-6. PubMed ID: 23286472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors and clinical significance of angiographically detected distal embolization after primary percutaneous coronary interventions.
    Izgi A; Kirma C; Tanalp AC; Dundar C; Oduncu V; Aung SM; Sonmez K; Mutlu B; Mansuroglu D
    Coron Artery Dis; 2007 Sep; 18(6):443-9. PubMed ID: 17700215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease.
    Ramadan MM; Kodama M; Mitsuma W; Ito M; Kashimura T; Ikrar T; Hirono S; Okura Y; Aizawa Y
    Am J Cardiol; 2006 Oct; 98(7):915-7. PubMed ID: 16996873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention.
    Robertson L; Grip L; Mattsson Hultén L; Hulthe J; Wiklund O
    J Intern Med; 2007 Dec; 262(6):659-67. PubMed ID: 17927738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of percutaneous coronary intervention on inflammatory response and endothelial progenitor cell recruitment.
    Garg R; Tellez A; Alviar C; Granada J; Kleiman NS; Lev EI
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):205-9. PubMed ID: 18651648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris.
    Saleh N; Svane B; Jensen J; Hansson LO; Nordin M; Tornvall P
    Am Heart J; 2005 May; 149(5):876-82. PubMed ID: 15894971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
    Sorajja P; Gersh BJ; Cox DA; McLaughlin MG; Zimetbaum P; Costantini C; Stuckey T; Tcheng JE; Mehran R; Lansky AJ; Grines CL; Stone GW
    Eur Heart J; 2007 Jul; 28(14):1709-16. PubMed ID: 17556348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Culprit only versus complete coronary revascularization during primary PCI.
    Qarawani D; Nahir M; Abboud M; Hazanov Y; Hasin Y
    Int J Cardiol; 2008 Jan; 123(3):288-92. PubMed ID: 17428557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
    Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations of using a GuardWire temporary occlusion and aspiration system in patients with acute myocardial infarction: multicenter investigation of coronary artery protection with a distal occlusion device in acute myocardial infarction (MICADO).
    Matsuo A; Inoue N; Suzuki K; Nakamura R; Fujita H; Miki S; Yokoi Y
    J Invasive Cardiol; 2007 Mar; 19(3):132-8. PubMed ID: 17341781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.